(Q37981103)

English

The clinical significance of vancomycin minimum inhibitory concentration in Staphylococcus aureus infections: a systematic review and meta-analysis.

scientific article published on 02 February 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22302374%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

0 references

The clinical significance of vancomycin minimum inhibitory concentration in Staphylococcus aureus infections: a systematic review and meta-analysis (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22302374%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

0 references

Staphylococcus aureus

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

systematic review

1 reference

based on heuristic

inferred from title

David L Paterson

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22302374%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

author name string

S J van Hal

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22302374%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

T P Lodise

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22302374%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

language of work or name

0 references

publication date

2 February 2012

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22302374%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Clinical Infectious Diseases

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22302374%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

54

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22302374%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22302374%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

755-771

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22302374%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR935

21 January 2018

Methicillin-resistant Staphylococcus aureus disease in three communities

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR935

21 January 2018

A clone of methicillin-resistant Staphylococcus aureus among professional football players.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR935

21 January 2018

Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR935

21 January 2018

Microbiological features of vancomycin in the 21st century: minimum inhibitory concentration creep, bactericidal/static activity, and applied breakpoints to predict clinical outcomes or detect resistant strains

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR935

21 January 2018

Bacteremia due to Staphylococcus aureus with reduced susceptibility to vancomycin.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR935

21 January 2018

Heterogeneous vancomycin-intermediate susceptibility phenotype in bloodstream methicillin-resistant Staphylococcus aureus isolates from an international cohort of patients with infective endocarditis: prevalence, genotype, and clinical significance

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR935

21 January 2018

Methicillin-resistant Staphylococcus aureus bacteraemia and mortality in a teaching hospital

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR935

21 January 2018

Relationship between the MIC of vancomycin and clinical outcome in patients with MRSA nosocomial pneumonia

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR935

21 January 2018

Integrated analysis of CANVAS 1 and 2: phase 3, multicenter, randomized, double-blind studies to evaluate the safety and efficacy of ceftaroline versus vancomycin plus aztreonam in complicated skin and skin-structure infection

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR935

21 January 2018

Risk factors for treatment failure in orthopedic device-related methicillin-resistant Staphylococcus aureus infection.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR935

21 January 2018

Vancomycin-intermediate and -resistant Staphylococcus aureus: what the infectious disease specialist needs to know

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR935

21 January 2018

Relationship of vancomycin minimum inhibitory concentration to mortality in patients with methicillin-resistant Staphylococcus aureus hospital-acquired, ventilator-associated, or health-care-associated pneumonia

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR935

21 January 2018

Persistent Staphylococcus aureus bacteremia: an analysis of risk factors and outcomes

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR935

21 January 2018

High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR935

21 January 2018

Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR935

21 January 2018

Prospective comparison of the clinical impacts of heterogeneous vancomycin-intermediate methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-susceptible MRSA.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR935

21 January 2018

Comparison of method-specific vancomycin minimum inhibitory concentration values and their predictability for treatment outcome of meticillin-resistant Staphylococcus aureus (MRSA) infections

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR935

21 January 2018

Clinical characteristics and risk factors for mortality in patients with meningitis caused by Staphylococcus aureus and vancomycin minimal inhibitory concentrations against these isolates

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR935

21 January 2018

Frequency of reduced vancomycin susceptibility and heterogeneous subpopulation in persistent or recurrent methicillin-resistant Staphylococcus aureus bacteremia

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR935

21 January 2018

Is high vancomycin minimum inhibitory concentration a good marker to predict the outcome of methicillin-resistant Staphylococcus aureus bacteremia?

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR935

21 January 2018

Methicillin-resistant Staphylococcus aureus bacteremia: epidemiology, outcome, and laboratory characteristics in a tertiary referral center in the UK.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR935

21 January 2018

Outcome of patients with meticillin-resistant Staphylococcus aureus bacteraemia at an Emergency Department of a medical centre in Taiwan.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR935

21 January 2018

Risk factors for mortality in patients with persistent methicillin-resistant Staphylococcus aureus bacteraemia in a tertiary care hospital in Taiwan

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR935

21 January 2018

Relationship between vancomycin MIC and failure among patients with methicillin-resistant Staphylococcus aureus bacteremia treated with vancomycin

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR935

21 January 2018

Predicting high vancomycin minimum inhibitory concentration in methicillin-resistant Staphylococcus aureus bloodstream infections

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR935

21 January 2018

Clinical failure of vancomycin treatment of Staphylococcus aureus infection in a tertiary care hospital in southern Brazil

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR935

21 January 2018

Case-control study of the relationship between MRSA bacteremia with a vancomycin MIC of 2 microg/mL and risk factors, costs, and outcomes in inpatients undergoing hemodialysis.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR935

21 January 2018

Clinical features of heteroresistant vancomycin-intermediate Staphylococcus aureus bacteremia versus those of methicillin-resistant S. aureus bacteremia

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR935

21 January 2018

Vancomycin in vitro bactericidal activity and its relationship to efficacy in clearance of methicillin-resistant Staphylococcus aureus bacteremia

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR935

21 January 2018

Accessory gene regulator group II polymorphism in methicillin-resistant Staphylococcus aureus is predictive of failure of vancomycin therapy

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR935

21 January 2018

Vancomycin MIC plus heteroresistance and outcome of methicillin-resistant Staphylococcus aureus bacteremia: trends over 11 years

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR935

21 January 2018

Impact of reduced vancomycin susceptibility on the therapeutic outcome of MRSA bloodstream infections.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR935

21 January 2018

Clinical, microbiologic, and genetic determinants of persistent methicillin-resistant Staphylococcus aureus bacteremia

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR935

21 January 2018

Vancomycin minimum inhibitory concentration as a predictor of mortality in methicillin-resistant Staphylococcus aureus bacteremia: a second look

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR935

21 January 2018

Paradoxical relationship between the clinical outcome of Staphylococcus aureus bacteremia and the minimum inhibitory concentration of vancomycin

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR935

21 January 2018

Telavancin versus vancomycin for hospital-acquired pneumonia due to gram-positive pathogens

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR935

21 January 2018

Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR935

21 January 2018

Increased mortality with accessory gene regulator (agr) dysfunction in Staphylococcus aureus among bacteremic patients

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR935

21 January 2018

The importance of a judicious and early empiric choice of antimicrobial for methicillin-resistant Staphylococcus aureus bacteraemia

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR935

21 January 2018

Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR935

21 January 2018

Vancomycin heteroresistance is associated with reduced mortality in ST239 methicillin-resistant Staphylococcus aureus blood stream infections.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR935

21 January 2018

Nosocomial methicillin-resistant Staphylococcus aureus (MRSA) bacteremia in Taiwan: mortality analyses and the impact of vancomycin, MIC = 2 mg/L, by the broth microdilution method

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR935

21 January 2018

Clinical characteristics, outcomes, and microbiologic features associated with methicillin-resistant Staphylococcus aureus bacteremia in pediatric patients treated with vancomycin

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR935

21 January 2018

Can clinical and molecular epidemiologic parameters guide empiric treatment with vancomycin for methicillin-resistant Staphylococcus aureus infections?

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR935

21 January 2018

Predictors of persistent methicillin-resistant Staphylococcus aureus bacteraemia in patients treated with vancomycin

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR935

21 January 2018

Performance of various testing methodologies for detection of heteroresistant vancomycin-intermediate Staphylococcus aureus in bloodstream isolates

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR935

21 January 2018

Systematic review and meta-analysis of the significance of heterogeneous vancomycin-intermediate Staphylococcus aureus isolates

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR935

21 January 2018

Pharmacodynamics of vancomycin and other antimicrobials in patients with Staphylococcus aureus lower respiratory tract infections

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR935

21 January 2018

Vancomycin: we can't get there from here.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR935

21 January 2018

Correlation between vancomycin and daptomycin MIC values for methicillin-susceptible and methicillin-resistant Staphylococcus aureus by 3 testing methodologies

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR935

21 January 2018

Vancomycin MIC susceptibility testing of methicillin-susceptible and methicillin-resistant Staphylococcus aureus isolates: a comparison between Etest® and an automated testing method

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR935

21 January 2018

Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR935

21 January 2018

Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR935

21 January 2018

Emergence of daptomycin resistance following vancomycin-unresponsive Staphylococcus aureus bacteraemia in a daptomycin-naïve patient--a review of the literature

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR935

21 January 2018

Antibiotic Choice May Not Explain Poorer Outcomes in Patients With Staphylococcus aureus Bacteremia and High Vancomycin Minimum Inhibitory Concentrations

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR935

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37981103&oldid=2106469452"